Skip to main content
Swervepay logo

Swervepay

Security and trust center evidence

finvi.comFinance and accountingLast verified 17 Sep 2026

Summary

Swervepay has 2 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Authorized. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

As of 17 Sep 2026, FedRAMP evidence shows Swervepay is listed in the FedRAMP registry as FedRAMP Authorized, with authorization issued 31 Jan 2023 by A-LIGN Compliance and Security, Inc. dba A-LIGN. As of 17 Sep 2026, PCI DSS evidence shows Swervepay is listed in the Visa Global Registry of Service Providers as PCI DSS validated, with validation issued 9 Aug 2016 and stated to run through 31 Jan 2027. As of 17 Sep 2026, no public evidence found for SOC 2 for Swervepay. As of 17 Sep 2026, no public evidence found for HIPAA or a BAA offering for Swervepay. As of 17 Sep 2026, no subprocessors were listed in the supplied evidence for Swervepay.

  • FedRAMP: listed in FedRAMP registry as FedRAMP Authorized, issued 31 Jan 2023 (auditor: A-LIGN Compliance and Security, Inc. dba A-LIGN); as of 17 Sep 2026
  • PCI DSS: listed in Visa Global Registry as PCI DSS validated, issued 9 Aug 2016, through 31 Jan 2027 (auditor: A-LIGN Compliance and Security, Inc. dba A-LIGN); as of 17 Sep 2026
  • SOC 2 and HIPAA: no public evidence found as of 17 Sep 2026

Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.

Among finance and accounting vendors

2verified rows

Category median 1, across 83 indexed finance and accounting vendors. Swervepay has more verified rows than 96 percent of them.

accounts receivablecollectionsdebt managementpayment automation

Compliance grid

Subprocessors

No subprocessor list captured yet.

Similar vendors with evidence

Related by product tags and the Finance and accounting category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.